Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02758808 · ClinicalTrials.gov registry record
Pulmonary Fibrosis Foundation Patient Registry
A clinical trial, sponsored by Pulmonary Fibrosis Foundation.
- Completed
- Registry status
- 2,004
- Enrollment target
NCT02758808 is a clinical trial that has completed, run by Pulmonary Fibrosis Foundation. The registered enrollment target is 2,004 participants.
The verdict
NCT02758808 has completed, sponsored by Pulmonary Fibrosis Foundation.
- COMPLETED
- Registry status
- 2,004 participants
- Enrollment target
Study Summary
The Pulmonary Fibrosis Foundation Patient Registry will collect data on at least 2,000 patients with interstitial lung disease (ILD) at approximately 40 clinical sites in the US. The Registry is targeting enrollment of approximately 60% of the 2,000 ILD participants to have idiopathic pulmonary fibrosis (IPF). The aim of the Registry is to create a cohort of well-characterized patients with interstitial lung disease (ILD) for participation in retrospective and prospective research
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,004 participants |
| Start Date | 2016-03-29 |
| Est. Completion | 2022-12-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02758808
The ClinicalTrials.gov registry entry for NCT02758808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,004 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulmonary Fibrosis Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02758808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02758808 about?
NCT02758808 is a clinical study titled "Pulmonary Fibrosis Foundation Patient Registry". The Pulmonary Fibrosis Foundation Patient Registry will collect data on at least 2,000 patients with interstitial lung disease (ILD) at approximately 40 clinical sites in the US. The Registry is targeting enrollment of approximately 60% of the 2,000 ILD participants to have idiopathic pulmonary fibr...
What is the current status of trial NCT02758808?
This trial is currently completed. The enrollment target is 2,004 participants. The study started on 2016-03-29. Estimated completion is 2022-12-16.
Who is sponsoring clinical trial NCT02758808?
This trial is sponsored by Pulmonary Fibrosis Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.